Table 3.2. Number and rates* of reported cases† of acute hepatitis C, by demographic characteristics — United States 2015–2019
Characteristics | 2015 No. | 2015 Rate* | 2016 No. | 2016 Rate* | 2017 No. | 2017 Rate* | 2018 No. | 2018 Rate* | 2019 No. | 2019 Rate* |
---|---|---|---|---|---|---|---|---|---|---|
Total § | 2,436 | 0.8 | 2,967 | 1.0 | 3,216 | 1.0 | 3,621 | 1.2 | 4,136 | 1.3 |
Age (yrs) | ||||||||||
0-19 | 99 | 0.1 | 86 | 0.1 | 103 | 0.1 | 81 | 0.1 | 63 | 0.1 |
20-29 | 999 | 2.4 | 1,135 | 2.7 | 1,189 | 2.7 | 1,310 | 3.0 | 1,262 | 2.9 |
30-39 | 682 | 1.7 | 868 | 2.2 | 937 | 2.3 | 1,070 | 2.6 | 1,347 | 3.2 |
40-49 | 337 | 0.9 | 452 | 1.2 | 441 | 1.1 | 494 | 1.3 | 664 | 1.7 |
50-59 | 240 | 0.6 | 264 | 0.6 | 332 | 0.8 | 366 | 0.9 | 442 | 1.1 |
≥60 | 77 | 0.1 | 141 | 0.2 | 185 | 0.3 | 295 | 0.4 | 358 | 0.5 |
Sex | ||||||||||
Male | 1,334 | 0.9 | 1,627 | 1.1 | 1,775 | 1.2 | 2,012 | 1.3 | 2,471 | 1.6 |
Female | 1,093 | 0.7 | 1,310 | 0.8 | 1,431 | 0.9 | 1,605 | 1.0 | 1,653 | 1.0 |
Race/ethnicity | ||||||||||
American Indian/Alaska Native | 39 | 1.8 | 70 | 3.1 | 67 | 2.9 | 83 | 3.6 | 83 | 3.6 |
Asian/Pacific Islander | 16 | 0.1 | 25 | 0.1 | 23 | 0.1 | 29 | 0.1 | 36 | 0.2 |
Black, non-Hispanic | 112 | 0.3 | 130 | 0.3 | 202 | 0.5 | 231 | 0.6 | 267 | 0.7 |
White, non-Hispanic | 1,724 | 0.9 | 2,109 | 1.1 | 2,227 | 1.2 | 2,405 | 1.3 | 2,683 | 1.4 |
Hispanic | 148 | 0.3 | 191 | 0.3 | 234 | 0.4 | 280 | 0.5 | 350 | 0.6 |
Urbanicity ¶ | ||||||||||
Urban | 1,812 | 0.7 | 2,227 | 0.8 | 2,397 | 0.9 | 2,782 | 1.0 | 3,275 | 1.2 |
Rural | 545 | 1.3 | 501 | 1.2 | 485 | 1.1 | 676 | 1.6 | 720 | 1.7 |
HHS Region: Regional Office # | ||||||||||
Region 1: Boston | 280 | 3.2 | 471 | 3.8 | 391 | 2.8 | 172 | 1.2 | 237 | 1.7 |
Region 2: New York | 251 | 0.9 | 301 | 1.0 | 313 | 1.1 | 332 | 1.2 | 405 | 1.4 |
Region 3: Philadelphia | 286 | 1.0 | 422 | 1.4 | 424 | 1.4 | 404 | 1.4 | 392 | 1.3 |
Region 4: Atlanta | 721 | 1.2 | 706 | 1.1 | 826 | 1.3 | 1,056 | 1.7 | 1,253 | 2.0 |
Region 5: Chicago | 475 | 0.9 | 615 | 1.2 | 692 | 1.3 | 977 | 1.9 | 1,053 | 2.0 |
Region 6: Dallas | 149 | 0.4 | 95 | 0.2 | 105 | 0.2 | 114 | 0.3 | 157 | 0.4 |
Region 7: Kansas City | 38 | 0.3 | 41 | 0.4 | 70 | 0.6 | 89 | 0.8 | 74 | 0.5 |
Region 8: Denver | 85 | 0.8 | 152 | 1.4 | 162 | 1.4 | 225 | 1.9 | 222 | 1.9 |
Region 9: San Francisco | 71 | 0.2 | 76 | 0.2 | 138 | 0.3 | 133 | 0.3 | 222 | 0.5 |
Region 10: Seattle | 80 | 0.6 | 88 | 0.7 | 95 | 0.7 | 119 | 0.9 | 121 | 0.9 |
* Rates per 100,000 population.
† Reported cases that met the classification criteria for a confirmed case. For the case definition, see https://ndc.services.cdc.gov/conditions/hepatitis-c-acute/.
§ Numbers reported in each category might not add up to the total number of reported cases in a year because of cases with missing data or, in the case of race/ethnicity, cases categorized as “Other.”
¶ Urbanicity was categorized according to the 2013 National Center for Health Statistics (NCHS) urban-rural classification scheme for counties and county-equivalent entities (https://www.cdc.gov/nchs/data_access/urban_rural.htm). Large central metropolitan, large fringe metropolitan, medium metropolitan, and small metropolitan counties were grouped as urban. Micropolitan and noncore counties were grouped as rural.
# US Department of Health and Human Services (HHS) regions were categorized according to the grouping of states and US territories assigned under each of the 10 HHS regional offices (https://www.hhs.gov/about/agencies/iea/regional-offices/index.html). For the purposes of this report, regions with US territories (Regions 2 and 9) contain data from states only.
This table summarizes the epidemiology of acute hepatitis C in the United States. During 2019, rates of acute hepatitis C were highest among persons aged 20–49 years, males, American Indian/Alaska Native persons, and those living in the US Department of Health and Human Services Regions 4 (Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, and Tennessee) and 5 (Illinois, Indiana, Michigan, Minnesota, Ohio, and Wisconsin). The geographic distribution of hepatitis C is similar to the geographic distribution of fatal overdose. By using urbanicity categories defined by the National Center of Health Statistics, CDC determined that the rates of acute hepatitis C remained higher in rural settings, compared with urban settings during 2015–2019, continuing a trend of increasing rates of hepatitis C disproportionately affecting White persons aged <30 years in nonurban areas of the United States. Among all acute hepatitis C cases reported during 2019, 79% occurred among persons aged 20–49 years; 65% occurred among non-Hispanic White persons; 79% occurred in urban areas; and 56% occurred in Health and Human Services Regions 4 and 5.
Source:
Jalal H, Buchanich JM, Sinclair DR, et al. Age and generational patterns of overdose death risk from opioids and other drugs. Nat Med 2020;26:699–704. doi: 10.1038/s41591-020-0855-y.
Suryaprasad, AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis 2014;59:1411–9. doi: 10.1093/cid/ciu643.
- Figure 3.1. Number of reported acute hepatitis C virus infection cases and estimated infections — United States, 2012–2019
- Figure 3.2. Rates of reported acute hepatitis C virus infections, by state — United States, 2018–2019
- Figure 3.3. Rates of reported acute hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Figure 3.4. Rates of reported acute hepatitis C virus infection, by age group — United States, 2004–2019
- Figure 3.5. Rates of reported acute hepatitis C virus infection, by sex — United States, 2004–2019
- Figure 3.6. Rates of reported acute hepatitis C virus infection, by race/ethnicity — United States, 2004–2019
- Figure 3.7. Availability of information regarding risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2019
- Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases, by sex and age — United States, 2019
- Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by jurisdiction — United States, 2019
- Table 3.1. Number and rates of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2015–2019
- Table 3.2. Number and rates of reported cases of acute hepatitis C, by demographic characteristics — United States 2015–2019
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2019
- Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Table 3.5. Number and rates of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2019
- Table 3.6. Number and rates of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2019
- Table 3.7. Number and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2015–2019
- Table 3.8. Number and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2015–2019